Business Wire

Cognito Therapeutics Presents Clinical Trial Data Highlighting Neuroprotective Potential of Spectris™ in Alzheimer’s Disease at AAIC 2025

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a clinical-stage neurotechnology company pioneering neuromodulation-based treatments for neurodegenerative diseases, announced five new poster ...
VentureBeat

Cogito raises $37 million to analyze call center data with AI

Boston-based call center analytics company Cogito today announced a $37 million funding round led by Goldman Sachs Growth Equity, Salesforce Ventures, and OpenView. Cogito will use the infusion of ...
Business Wire

Cognito Therapeutics Presents Phase 2 OVERTURE Study Open-Label Extension Data Showing Safety, Adherence and Durability of Treatment Benefits Over 18 Months

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a late-stage developer of disease-modifying therapies to treat neurodegenerative disorders, announced today continued active treatment in the ...
Indiatimes

Cogito Tech Emerges as the Shining Star in the Global Data Annotation Industry

The AI revolution has transformed the world, impacting various sectors such as healthcare, finance, and education by enhancing efficiency, personalizing experiences, and lowering costs. New Delhi ...